Sequoia Financial Advisors LLC Reduces Stake in Healthpeak Properties, Inc. $DOC

Sequoia Financial Advisors LLC lowered its position in Healthpeak Properties, Inc. (NYSE:DOC) by 17.7% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 127,919 shares of the real estate investment trust’s stock after selling 27,480 shares during the period. Sequoia Financial Advisors LLC’s holdings in Healthpeak Properties were worth $2,057,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of DOC. JPMorgan Chase & Co. boosted its position in Healthpeak Properties by 41.0% in the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after buying an additional 8,212,504 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Healthpeak Properties by 694.6% in the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after buying an additional 7,007,777 shares during the last quarter. Equity Investment Corp boosted its position in Healthpeak Properties by 209.6% in the third quarter. Equity Investment Corp now owns 5,330,948 shares of the real estate investment trust’s stock valued at $102,088,000 after buying an additional 3,608,849 shares during the last quarter. Bank of America Corp DE boosted its position in Healthpeak Properties by 28.5% in the third quarter. Bank of America Corp DE now owns 9,936,934 shares of the real estate investment trust’s stock valued at $190,292,000 after buying an additional 2,206,222 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its position in Healthpeak Properties by 176.4% in the third quarter. Russell Investments Group Ltd. now owns 3,063,569 shares of the real estate investment trust’s stock valued at $58,663,000 after buying an additional 1,955,273 shares during the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Down 0.2%

NYSE DOC opened at $19.61 on Monday. The business has a fifty day moving average price of $17.02 and a 200 day moving average price of $17.16. Healthpeak Properties, Inc. has a one year low of $15.70 and a one year high of $19.87. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. The company has a market cap of $13.52 billion, a P/E ratio of 61.28, a P/E/G ratio of 2.71 and a beta of 1.00.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, beating the consensus estimate of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The firm had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. During the same period in the prior year, the company earned $0.46 EPS. The firm’s revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Research analysts anticipate that Healthpeak Properties, Inc. will post 1.74 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Investors of record on Monday, June 15th will be paid a $0.1017 dividend. This represents a c) annualized dividend and a yield of 6.2%. The ex-dividend date of this dividend is Monday, June 15th. Healthpeak Properties’s dividend payout ratio is currently 381.25%.

Analyst Upgrades and Downgrades

DOC has been the topic of a number of recent research reports. Scotiabank upgraded Healthpeak Properties to a “hold” rating in a research report on Thursday, April 23rd. Argus lowered Healthpeak Properties from a “buy” rating to a “hold” rating in a research report on Thursday, February 5th. Morgan Stanley dropped their target price on Healthpeak Properties from $21.00 to $18.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 28th. UBS Group initiated coverage on Healthpeak Properties in a research report on Monday, April 20th. They issued a “neutral” rating and a $17.00 target price on the stock. Finally, Citigroup dropped their target price on Healthpeak Properties from $18.00 to $17.50 and set a “neutral” rating on the stock in a research report on Wednesday, April 1st. Five investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $18.04.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.